- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2198-4093
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Adoptive immunotherapy via CD4+ versus CD8+ T cells ; volume:3 ; number:4 ; day:15 ; month:4 ; year:2016 ; pages:1-8 ; date:3.2016
Biomedical research and therapy ; 3, Heft 4 (15.4.2016), 1-8, 3.2016
- Urheber
-
Phan-Lai, Vy
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.7603/s40730-016-0016-6
- URN
-
urn:nbn:de:101:1-2021082720541332166335
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Phan-Lai, Vy
- SpringerLink (Online service)
Ähnliche Objekte (12)
Adoptive immunotherapy of cancer with polyclonal, 108-fold hyperexpanded, CD4+ and CD8+ T cells
Adoptive immunotherapy against ovarian cancer
Nanoparticle-based modulation of CD4+ T cell effector and helper functions enhances adoptive immunotherapy
Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer
Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer
Adoptive immunotherapy for treatment of chronic hepatitis B
Adoptive immunotherapy for treatment of chronic hepatitis B
Immunregulatorische Funktion humaner TCRαβ+-CD4--CD8--T-Lymphozyten [TCR-alpha-beta+ CD4- CD8- T-Lymphozyten]
DOT1L inhibition attenuates graft-versus-host disease by allogeneic T cells in adoptive immunotherapy models
Optimization of adoptive immunotherapy with genetically engineered T cells
Adoptive T cell therapy: Addressing challenges in cancer immunotherapy
Adoptive cellular immunotherapy for solid neoplasms beyond CAR-T
Adoptive immunotherapy of cancer with polyclonal, 108-fold hyperexpanded, CD4+ and CD8+ T cells
Adoptive immunotherapy against ovarian cancer
Nanoparticle-based modulation of CD4+ T cell effector and helper functions enhances adoptive immunotherapy
Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer
Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer
Adoptive immunotherapy for treatment of chronic hepatitis B
Adoptive immunotherapy for treatment of chronic hepatitis B
Immunregulatorische Funktion humaner TCRαβ+-CD4--CD8--T-Lymphozyten [TCR-alpha-beta+ CD4- CD8- T-Lymphozyten]
DOT1L inhibition attenuates graft-versus-host disease by allogeneic T cells in adoptive immunotherapy models
Optimization of adoptive immunotherapy with genetically engineered T cells
Adoptive T cell therapy: Addressing challenges in cancer immunotherapy
Adoptive cellular immunotherapy for solid neoplasms beyond CAR-T
Adoptive immunotherapy of cancer with polyclonal, 108-fold hyperexpanded, CD4+ and CD8+ T cells
Adoptive immunotherapy against ovarian cancer
Nanoparticle-based modulation of CD4+ T cell effector and helper functions enhances adoptive immunotherapy
Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer
Microbial short-chain fatty acids modulate CD8+ T cell responses and improve adoptive immunotherapy for cancer
Adoptive immunotherapy for treatment of chronic hepatitis B
Adoptive immunotherapy for treatment of chronic hepatitis B
Immunregulatorische Funktion humaner TCRαβ+-CD4--CD8--T-Lymphozyten [TCR-alpha-beta+ CD4- CD8- T-Lymphozyten]
DOT1L inhibition attenuates graft-versus-host disease by allogeneic T cells in adoptive immunotherapy models
Optimization of adoptive immunotherapy with genetically engineered T cells
Adoptive T cell therapy: Addressing challenges in cancer immunotherapy